Immunization and promotion of health in the field of nursing care. Immnization applied to cancer
DOI:
https://doi.org/10.60108/ce.73Keywords:
cancer; immunotherapy; check points; radiotherapyAbstract
Cancer is a disease caused by cells that multiply uncontrollably and autonomously, invading other tissues. The role of the Immune System in the treatment of cancer has been validated by numerous studies and clinical trials. Recent advances in immunological therapies have been shown to improve patient survival. The purpose of this article is to gather and review publications that analyze studies and clinical trials that in turn check if there is evidence that these therapies are working, either as a single treatment or combined with more traditional therapies (radiotherapy and chemotherapy); They also evaluate its toxicity and adverse effects.
References
Inmunología del cáncer [Internet]. Google Books. 2018 [cited 11 December 2018]. Available from: https://books.google.es/books?hl=es&lr=&id=AyvNWKXhXGAC&oi=fnd&pg=PA5&dq=INMUNOLOGIA+APLICADA+AL+CANCER&ots=AC767Snr5C&sig=bgkiTWcRKlVO3yOByiTsslcGLEg
Juan Otero, M., and Sirera, R. (2015). Inmunoterapia del cáncer. Realidades y perspectivas – Barcelona: Elsevier.
Burnet FM. (1957). Cancer, a biological approach. Br Med J.1:841-47.
Burnet, F.M. (1971). Immunological surveillance in neoplasia. Transplant.Rev. 7, 3–25.
Infantes S. [Internet]. Dialnet.unirioja.es. 2019 [cited 9 January 2019]. Available from: https://dialnet.unirioja.es/descarga/articulo/6140630.pdf
Gallego L, Dávila D. [Internet]. Revistas.ces.edu.co. 2019 [cited 9 January 2019]. Available from: http://revistas.ces.edu.co/index.php/medicina/article/viewFile/1120/705
Zhu J, Li R, Tiselius E, Roudi R, Teghararian O, Suo C et al. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. 2019.
FERNANDEZ M. [Internet]. Dialnet.unirioja.es. 2019 [cited 9 January 2019]. Available from: https://dialnet.unirioja.es/descarga/articulo/6296516.pdf
Weber J. Challenging Cases: Management of Immune-Related Toxicity.
American Society of Clinical Oncology Educational Book. 2018;(38):179-183.
Pérez-Ruiz E, Etxeberria I, Rodriguez-Ruiz M, Melero I. Anti-CD137 and PD-1/PD-L1 Antibodies En Route toward Clinical Synergy. 2019.
González B, Bueno D, Rubio P, San Román S, Plaza D, Sastre A et al. Aspectos inmunológicos de la leucemia mieloblástica aguda. 2019.
UpToDate [Internet]. Uptodate.com. 2019 [cited 8 January 2019]. Available from: https://www.uptodate.com/contents/principles-of-cancer-immunotherapy#!
UpToDate [Internet]. Uptodate.com. 2019 [cited 8 January 2019]. Available from: https://www.uptodate.com/contents/principles-of-cancer-immunotherapy#!
Advances in Radiation Oncology | Vol 3, Issue 4, Pages 471-704 (October–December 2018) | ScienceDirect.com [Internet]. Sciencedirect.com. 2019 [cited 8 January 2019]. Available from: https://www.sciencedirect.com/journal/advances-in-radiation-oncology/vol/3/issue/4
Verma V, Cushman T, Tang C, Welsh J. Toxicity of radiation and immunotherapy combinations. 2019.
Ko E, Benjamin K, Formenti S. Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation. 2019.
Inmunoterapia contra el cáncer [Internet]. Bemygene - Health Company. 2019 [cited 13 January 2019]. Available from: https://bemygene.com/inmunoterapia-contra-el-cancer/
Downloads
Published
How to Cite
Issue
Section
License
En caso de que el artículo sea publicado, los autores aceptan transferir todos los derechos del trabajo presentado, incluidos los derechos de autor y aquellos relativos a la transmisión electrónica, exclusivamente a CODEM, de manera universal, en todos los idiomas, una vez que el trabajo haya sido aceptado para su publicación dentro de la revista electrónica CONOCIMIENTO ENFERMERO.
El autor podrá hacer copias ilimitadas del trabajo para uso docente, reutilizarlo en su totalidad o parcialmente en un libro escrito por el autor o hacer copias para su distribución en la institución en la que trabaja. CODEM hará mención al nombre del autor en las publicaciones que se realicen del trabajo.
